1. The heterogeneity of intraductal carcinoma of the prostate is associated with different efficacy of standard first‐line therapy for patients with metastatic castration‐resistant prostate cancer. Issue 15 (26th August 2021) Authors: Wang, Zhipeng; Zhu, Sha; Zhao, Jinge; Nie, Ling; Chen, Xueqin; Zhang, Mengni; Chen, Ni; Sun, Guangxi; Chen, Junru; Ni, Yuchao; Dai, Jindong; Liu, Zhenhua; Tao, Ronggui; Zhang, Xingming; Zhu, Xudong; Zhang, Haoran; Liang, Jiayu; Wang, Zilin; He, Ben; Shen, Pengfei Journal: Prostate Issue: Volume 81:Issue 15(2021) Page Start: 1191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗